Novartis (NVS)

Add to Watchlists
Create an Alert
84.59 -1.58  -1.83% NYSE Apr 24, 8:00PM BATS Real time Currency in USD

Novartis Free Cash Flow (Quarterly):

3.325B for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

Novartis Free Cash Flow (Quarterly) Chart

Export Data
Save Image

Novartis Historical Free Cash Flow (Quarterly) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 3.325B
Sept. 30, 2013 3.45B
June 30, 2013 1.65B
March 31, 2013 1.178B
Dec. 31, 2012 3.652B
Sept. 30, 2012 3.311B
June 30, 2012 2.271B
March 31, 2012 1.892B
Dec. 31, 2011 4.049B
Sept. 30, 2011 3.65B
June 30, 2011 2.822B
March 31, 2011 1.401B
Dec. 31, 2010 3.833B
Sept. 30, 2010 2.835B
June 30, 2010 2.308B
March 31, 2010 2.859B
Dec. 31, 2009 3.472B
Sept. 30, 2009 2.638B
June 30, 2009 1.899B
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
   
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade
March 31, 2006 Upgrade
Dec. 31, 2005 Upgrade
Sept. 30, 2005 Upgrade
June 30, 2005 Upgrade
March 31, 2005 Upgrade
Dec. 31, 2004 Upgrade
Sept. 30, 2004 Upgrade
June 30, 2004 Upgrade
March 31, 2004 Upgrade
Dec. 31, 2003 Upgrade
Sept. 30, 2003 Upgrade
June 30, 2003 Upgrade
March 31, 2003 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Free Cash Flow

Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.

According to many investors, free cash flow is the best indication of a company's ability to generate cash.
Learn More

Get data for
Advertisement

NVS Free Cash Flow (Quarterly) Benchmarks

Companies
Pfizer 5.11B
Roche Holding
Johnson & Johnson 2.71B

NVS Free Cash Flow (Quarterly) Range, Past 5 Years

Minimum 1.178B Mar 2013
Maximum 4.049B Dec 2011
Average 2.763B
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.